{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:08:28Z","timestamp":1785784108853,"version":"3.56.0"},"reference-count":84,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T00:00:00Z","timestamp":1611878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Preventing premature ovarian failure (POF) is a major challenge in oncology. With conventional regimens, cytotoxicity-associated POF involves primordial follicles (PF) pool depletion by apoptosis or overactivation mechanisms, notably mediated by the ABL\/TAp63 and PI3K\/Akt\/mTOR pathways. New anticancer treatments have been designed to target pathways implicated in tumor growth. Although concerns regarding fertility arise with these targeted therapies, we hypothesized that targeted therapies may exert off-tumor effects on PF that might delay POF. We provide an overview of evidence concerning these off-tumor effects on PF. Limitations and future potential implications of these findings are discussed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>PubMed was searched by combining Boolean operators with the following keywords: fertility, ovarian, follicle, anti-tumoral, cancer, targeted, cytotoxic, and chemotherapy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Cisplatin-related PF apoptosis via the ABL\/TAp63 pathway was targeted with a tyrosine kinase inhibitor, imatinib, in mice, but effects were recently challenged by findings on human ovarian xenografts in mice. In cyclophosphamide-treated mice, PI3K\/Akt\/mTOR pathway inhibition with mTOR inhibitors and AS101 preserved the PF pool. Proteasome and GSK3 inhibitors were evaluated for direct and indirect follicle DNA damage prevention. Surprisingly, evidence for cytotoxic drug association with PF pool preservation was found. We also describe selected non-anticancer molecules that may minimize gonadotoxicity.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Not all anticancer treatments are associated with POF, particularly since the advent of targeted therapies. The feasibility of associating a protective drug targeting PF exhaustion mechanisms with cytotoxic treatments should be evaluated, as a way of decreasing the need for conventional fertility preservation techniques. Further evaluations are required for transfer into clinical practice.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Implications for Practice<\/jats:title>\n                  <jats:p>Anticancer therapies are associated with infertility in 10%\u201370% of patients, which is the result of primordial follicles pool depletion. Alone or associated with gonadotoxic treatments, some targeted therapies may exert favorable off-targets effects on the primordial follicle pool by slowing down their exhaustion. Current evidence of these effects relies on murine models or human in vitro models. Evaluation of these protective strategies in humans is challenging; however, if these results are confirmed with clinical and biological data, it not only could be a new approach to female fertility preservation but also would change standard fertility strategies.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1002\/onco.13675","type":"journal-article","created":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T07:21:07Z","timestamp":1610954467000},"page":"492-503","source":"Crossref","is-referenced-by-count":20,"title":["Can Some Anticancer Treatments Preserve the Ovarian Reserve?"],"prefix":"10.1093","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9568-3358","authenticated-orcid":false,"given":"Nicolas","family":"Vallet","sequence":"first","affiliation":[{"name":"Department of Hematology and Cellular Therapy, Tours University Hospital, Tours, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Boissel","sequence":"additional","affiliation":[{"name":"Department of Hematology, Adolescent and Young Adults Unit, Fertility Preservation, Saint Louis Hospital AP-, HP, Paris, France"},{"name":"Paris University, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Elefant","sequence":"additional","affiliation":[{"name":"Centre de R\u00e9f\u00e9rence sur les Agents T\u00e9ratog\u00e8nes (CRAT), Armand Trousseau Hospital AP-, HP, Paris, France"},{"name":"Faculty of Medicine, Sorbonne University, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Chevillon","sequence":"additional","affiliation":[{"name":"Department of Hematology, Adolescent and Young Adults Unit, Fertility Preservation, Saint Louis Hospital AP-, HP, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Pasquer","sequence":"additional","affiliation":[{"name":"Department of Hematology, Adolescent and Young Adults Unit, Fertility Preservation, Saint Louis Hospital AP-, HP, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Calvo","sequence":"additional","affiliation":[{"name":"Pediatric Hematology Department, Robert Debr\u00e9 Hospital AP-, HP, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Dhedin","sequence":"additional","affiliation":[{"name":"Department of Hematology, Adolescent and Young Adults Unit, Fertility Preservation, Saint Louis Hospital AP-, HP, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Poirot","sequence":"additional","affiliation":[{"name":"Department of Hematology, Adolescent and Young Adults Unit, Fertility Preservation, Saint Louis Hospital AP-, HP, Paris, France"},{"name":"Faculty of Medicine, Sorbonne University, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,1,29]]},"reference":[{"key":"2022020821442557600_onco13675-bib-0001","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1093\/annonc\/mdz284","article-title":"Preserving fertility in female patients with hematological malignancies: A multidisciplinary oncofertility approach","volume":"30","author":"Salama","year":"2019","journal-title":"Ann Oncol"},{"key":"2022020821442557600_onco13675-bib-0002","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s40618-016-0467-z","article-title":"Premature ovarian insufficiency: The context of long-term effects","volume":"39","author":"Podfigurna-Stopa","year":"2016","journal-title":"J Endocrinol Invest"},{"key":"2022020821442557600_onco13675-bib-0003","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1210\/jc.2016-3723","article-title":"Premature ovarian insufficiency in childhood cancer survivors: A report from the St. Jude lifetime cohort","volume":"102","author":"Chemaitilly","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"2022020821442557600_onco13675-bib-0004","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2016.27.e22","article-title":"Toward precision medicine for preserving fertility in cancer patients: Existing and emerging fertility preservation options for women","volume":"27","author":"Kim","year":"2016","journal-title":"J Gynecol Oncol"},{"key":"2022020821442557600_onco13675-bib-0005","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S0140-6736(11)61781-9","article-title":"Induction of puberty by autograft of cryopreserved ovarian tissue","volume":"379","author":"Poirot","year":"2012","journal-title":"Lancet"},{"key":"2022020821442557600_onco13675-bib-0006","doi-asserted-by":"crossref","first-page":"e360","DOI":"10.3324\/haematol.2018.211094","article-title":"Post-transplant outcome of ovarian tissue cryopreserved after chemotherapy in hematological malignancies","volume":"104","author":"Poirot","year":"2019","journal-title":"Haematologica"},{"key":"2022020821442557600_onco13675-bib-0007","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1210\/er.2008-0048","article-title":"Molecular mechanisms underlying the activation of mammalian primordial follicles","volume":"30","author":"Adhikari","year":"2009","journal-title":"Endocr Rev"},{"key":"2022020821442557600_onco13675-bib-0008","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.tem.2009.10.001","article-title":"Mechanisms maintaining the dormancy and survival of mammalian primordial follicles","volume":"21","author":"Reddy","year":"2010","journal-title":"Trends Endocrinol Metab"},{"key":"2022020821442557600_onco13675-bib-0009","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/nm.2033","article-title":"Inhibition of the c-Abl-TAp63 pathway protects mouse oocytes from chemotherapy-induced death","volume":"15","author":"Gonfloni","year":"2009","journal-title":"Nat Med"},{"key":"2022020821442557600_onco13675-bib-0010","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/humrep\/dem408","article-title":"A new model of reproductive aging: The decline in ovarian non-growing follicle number from birth to menopause","volume":"23","author":"Hansen","year":"2008","journal-title":"Hum Reprod"},{"key":"2022020821442557600_onco13675-bib-0011","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1126\/science.1152257","article-title":"Oocyte-specific deletion of Pten causes premature activation of the primordial follicle pool","volume":"319","author":"Reddy","year":"2008","journal-title":"Science"},{"key":"2022020821442557600_onco13675-bib-0012","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1530\/rep.1.00978","article-title":"Platelet-derived growth factor modulates the primordial to primary follicle transition","volume":"131","author":"Nilsson","year":"2006","journal-title":"Reproduction"},{"key":"2022020821442557600_onco13675-bib-0013","first-page":"533","article-title":"Janus kinase JAK1 maintains the ovarian reserve of primordial follicles in the mouse ovary","volume":"24","author":"Sutherland","year":"2018","journal-title":"Mol Hum Reprod"},{"key":"2022020821442557600_onco13675-bib-0014","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1093\/humrep\/dey250","article-title":"Dynamics of PI3K and Hippo signaling pathways during in vitro human follicle activation","volume":"33","author":"Grosbois","year":"2018","journal-title":"Hum Reprod"},{"key":"2022020821442557600_onco13675-bib-0015","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/humupd\/dms022","article-title":"How do chemotherapeutic agents damage the ovary?","volume":"18","author":"Morgan","year":"2012","journal-title":"Hum Reprod Update"},{"key":"2022020821442557600_onco13675-bib-0016","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1002\/cncr.23071","article-title":"Quantitative assessment of the impact of chemotherapy on ovarian follicle reserve and stromal function","volume":"110","author":"Oktem","year":"2007","journal-title":"Cancer"},{"key":"2022020821442557600_onco13675-bib-0017","doi-asserted-by":"crossref","first-page":"10159","DOI":"10.1158\/0008-5472.CAN-07-2042","article-title":"A novel ovarian xenografting model to characterize the impact of chemotherapy agents on human primordial follicle reserve","volume":"67","author":"Oktem","year":"2007","journal-title":"Cancer Res"},{"key":"2022020821442557600_onco13675-bib-0018","doi-asserted-by":"crossref","DOI":"10.1186\/s13048-017-0350-3","article-title":"Rapamycin prevents cyclophosphamide-induced over-activation of primordial follicle pool through PI3K\/Akt\/mTOR signaling pathway in vivo","volume":"10","author":"Zhou","year":"2017","journal-title":"J Ovarian Res"},{"key":"2022020821442557600_onco13675-bib-0019","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1073\/pnas.1617233114","article-title":"mTORC1\/2 inhibition preserves ovarian function and fertility during genotoxic chemotherapy","volume":"114","author":"Goldman","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022020821442557600_onco13675-bib-0020","doi-asserted-by":"crossref","first-page":"185ra62","DOI":"10.1126\/scitranslmed.3005402","article-title":"Cyclophosphamide triggers follicle activation and \u201cburnout\u201d; AS101 prevents follicle loss and preserves fertility","volume":"5","author":"Kalich-Philosoph","year":"2013","journal-title":"Sci Transl Med"},{"key":"2022020821442557600_onco13675-bib-0021","doi-asserted-by":"crossref","first-page":"782","DOI":"10.18632\/aging.100363","article-title":"Mechanisms of chemotherapy-induced human ovarian aging: Double strand DNA breaks and microvascular compromise","volume":"3","author":"Soleimani","year":"2011","journal-title":"Aging (Albany NY)"},{"key":"2022020821442557600_onco13675-bib-0022","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070117","article-title":"Cisplatin and doxorubicin induce distinct mechanisms of ovarian follicle loss; imatinib provides selective protection only against cisplatin","volume":"8","author":"Morgan","year":"2013","journal-title":"PLoS One"},{"key":"2022020821442557600_onco13675-bib-0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108963","article-title":"Protective properties of glycogen synthase kinase-3 inhibition against doxorubicin-induced oxidative damage to mouse ovarian reserve","volume":"116","author":"Niringiyumukiza","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"2022020821442557600_onco13675-bib-0024","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/nm.2889","article-title":"Cisplatin-induced primordial follicle oocyte killing and loss of fertility are not prevented by imatinib","volume":"18","author":"Kerr","year":"2012","journal-title":"Nat Med"},{"key":"2022020821442557600_onco13675-bib-0025","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1038\/nm.2852","article-title":"Reply to: Cisplatin-induced primordial follicle oocyte killing and loss of fertility are not prevented by imatinib","volume":"18","author":"Maiani","year":"2012","journal-title":"Nat Med"},{"key":"2022020821442557600_onco13675-bib-0026","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/cdd.2013.31","article-title":"Rescue of platinum-damaged oocytes from programmed cell death through inactivation of the p53 family signaling network","volume":"20","author":"Kim","year":"2013","journal-title":"Cell Death Differ"},{"key":"2022020821442557600_onco13675-bib-0027","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.2217\/fon-2016-0032","article-title":"Doxorubicin and cisplatin induce apoptosis in ovarian stromal cells obtained from cryopreserved human ovarian tissue","volume":"12","author":"Fabbri","year":"2016","journal-title":"Futur Oncol"},{"key":"2022020821442557600_onco13675-bib-0028","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023492","article-title":"In vivo bioimaging as a novel strategy to detect doxorubicin-induced damage to gonadal blood vessels","volume":"6","author":"Bar-Joseph","year":"2011","journal-title":"PLoS One"},{"key":"2022020821442557600_onco13675-bib-0029","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nm0596-561","article-title":"Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells","volume":"2","author":"Druker","year":"1996","journal-title":"Nat Med"},{"key":"2022020821442557600_onco13675-bib-0030","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/nbt1328","article-title":"Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors","volume":"25","author":"Bantscheff","year":"2007","journal-title":"Nat Biotechnol"},{"key":"2022020821442557600_onco13675-bib-0031","first-page":"139","article-title":"Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors","volume":"295","author":"Buchdunger","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"2022020821442557600_onco13675-bib-0032","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1056\/NEJMoa020461","article-title":"Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors","volume":"347","author":"Demetri","year":"2002","journal-title":"N Engl J Med"},{"key":"2022020821442557600_onco13675-bib-0033","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s11060-019-03194-z","article-title":"Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North Central Cancer Treatment Group Study N0272 (ALLIANCE\/NCCTG)","volume":"143","author":"Jaeckle","year":"2019","journal-title":"J Neurooncol"},{"key":"2022020821442557600_onco13675-bib-0034","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.leukres.2011.09.025","article-title":"Imatinib mesylate at therapeutic doses has no impact on folliculogenesis or spermatogenesis in a leukaemic mouse model","volume":"36","author":"Schultheis","year":"2012","journal-title":"Leuk Res"},{"key":"2022020821442557600_onco13675-bib-0035","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.repbio.2016.11.003","article-title":"Developmental effects of imatinib mesylate on follicle assembly and early activation of primordial follicle pool in postnatal rat ovary","volume":"17","author":"Asadi-azarbaijani","year":"2017","journal-title":"Reprod Biol"},{"key":"2022020821442557600_onco13675-bib-0036","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-018-1026-7","article-title":"C-Abl is not activated in DNA damage-induced and Tap63-mediated oocyte apoptosis in human ovary","volume":"9","author":"Bildik","year":"2018","journal-title":"Cell Death Dis"},{"key":"2022020821442557600_onco13675-bib-0037","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/14737140.2017.1272415","article-title":"Sunitinib in kidney cancer: 10\u2009years of experience and development","volume":"17","author":"Nassif","year":"2017","journal-title":"Expert Rev Anticancer Ther"},{"key":"2022020821442557600_onco13675-bib-0038","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152872","article-title":"The tyrosine kinase inhibitor sunitinib affects ovulation but not ovarian reserve in mouse: A preclinical study","volume":"11","author":"Bernard","year":"2016","journal-title":"PLoS One"},{"key":"2022020821442557600_onco13675-bib-0039","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1523-1755.2001.00460.x","article-title":"Rapamycin in transplantation: A review of the evidence","volume":"59","author":"Saunders","year":"2001","journal-title":"Kidney Int"},{"key":"2022020821442557600_onco13675-bib-0040","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ctrv.2018.07.013","article-title":"Everolimus-based combination therapies for HR+, HER2\u2212 metastatic breast cancer","volume":"69","author":"O'Shaughnessy","year":"2018","journal-title":"Cancer Treat Rev"},{"key":"2022020821442557600_onco13675-bib-0041","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41409-019-0633-y","article-title":"A monocentric study of steroid-refractory acute graft-versus-host disease treatment with tacrolimus and mTOR inhibitor","volume":"55","author":"Xhaard","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"2022020821442557600_onco13675-bib-0042","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053810","article-title":"Pharmacological inhibition of mTORC1 prevents over-activation of the primordial follicle pool in response to elevated PI3K signaling","volume":"8","author":"Adhikari","year":"2013","journal-title":"PLoS One"},{"key":"2022020821442557600_onco13675-bib-0043","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.gene.2013.03.039","article-title":"Rapamycin preserves the follicle pool reserve and prolongs the ovarian lifespan of female rats via modulating mTOR activation and sirtuin expression","volume":"523","author":"Zhang","year":"2013","journal-title":"Gene"},{"key":"2022020821442557600_onco13675-bib-0044","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.bcp.2006.06.015","article-title":"The immunomodulator AS101 induces growth arrest and apoptosis in multiple myeloma: Association with the Akt\/survivin pathway","volume":"72","author":"Hayun","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"2022020821442557600_onco13675-bib-0045","article-title":"Will A et al. Bortezomib for the treatment of multiple myeloma","volume":"4","author":"Scott","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"2022020821442557600_onco13675-bib-0046","first-page":"2467","article-title":"Mechanism of specific nuclear transport of adriamycin: The mode of nuclear translocation of adriamycin-proteasome complex","volume":"61","author":"Kiyomiya","year":"2001","journal-title":"Cancer Res"},{"key":"2022020821442557600_onco13675-bib-0047","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108174","article-title":"Bortezomib prevents acute doxorubicin ovarian insult and follicle demise, improving the fertility window and pup birth weight in mice","volume":"9","author":"Roti Roti","year":"2014","journal-title":"PLoS One"},{"key":"2022020821442557600_onco13675-bib-0048","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jbior.2017.06.003","volume":"65","author":"Hermida","year":"2017","journal-title":"Adv Biol Regul"},{"key":"2022020821442557600_onco13675-bib-0049","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1471-4159.2007.05124.x","article-title":"GSK-3beta down-regulates the transcription factor Nrf2 after oxidant damage: Relevance to exposure of neuronal cells to oxidative stress","volume":"105","author":"Rojo","year":"2008","journal-title":"J Neurochem"},{"key":"2022020821442557600_onco13675-bib-0050","first-page":"165","article-title":"Non-growing follicle density is increased following Adriamycin, bleomycin, vinblastine and dacarbazine (ABVD) chemotherapy in the adult human ovary","volume":"32","author":"McLaughlin","year":"2017","journal-title":"Hum Reprod"},{"key":"2022020821442557600_onco13675-bib-0051","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1200\/JCO.2008.20.1541","article-title":"Fertility of female survivors of childhood cancer: A report from the childhood cancer survivor study","volume":"27","author":"Green","year":"2009","journal-title":"J Clin Oncol"},{"key":"2022020821442557600_onco13675-bib-0052","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/toxsci\/kfz022","article-title":"Vincristine chemotherapy induces atresia of growing ovarian follicles in mice","volume":"169","author":"Winship","year":"2019","journal-title":"Toxicol Sci"},{"key":"2022020821442557600_onco13675-bib-0053","volume-title":"Sphingosine-1-phosphate","author":"The Human Metabolome Database"},{"key":"2022020821442557600_onco13675-bib-0054","volume-title":"Ceramide-1-phosphate","author":"The Human Metabolome Database"},{"key":"2022020821442557600_onco13675-bib-0055","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/humrep\/det391","article-title":"Sphingosine-1-phosphate prevents chemotherapy-induced human primordial follicle death","volume":"29","author":"Fang","year":"2014","journal-title":"Hum Reprod"},{"key":"2022020821442557600_onco13675-bib-0056","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.rbmo.2014.07.014","article-title":"Targeted anti-apoptosis activity for ovarian protection against chemotherapy-induced ovarian gonadotoxicity","volume":"29","author":"Tan","year":"2014","journal-title":"Reprod Biomed Online"},{"key":"2022020821442557600_onco13675-bib-0057","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1093\/humrep\/dey045","article-title":"Ceramide-1-phosphate has protective properties against cyclophosphamide-induced ovarian damage in a mice model of premature ovarian failure","volume":"33","author":"Pascuali","year":"2018","journal-title":"Hum Reprod"},{"key":"2022020821442557600_onco13675-bib-0058","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1210\/clinem\/dgaa513","article-title":"Anti-M\u00fcllerian hormone and ovarian reserve: Update on assessing ovarian function","volume":"105","author":"Moolhuijsen","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"2022020821442557600_onco13675-bib-0059","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1093\/humrep\/del165","article-title":"Anti-M\u00fcllerian hormone inhibits initiation of growth of human primordial ovarian follicles in vitro","volume":"21","author":"Carlsson","year":"2006","journal-title":"Hum Reprod"},{"key":"2022020821442557600_onco13675-bib-0060","doi-asserted-by":"crossref","first-page":"E1688","DOI":"10.1073\/pnas.1620729114","article-title":"AMH\/MIS as a contraceptive that protects the ovarian reserve during chemotherapy","volume":"114","author":"Kano","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022020821442557600_onco13675-bib-0061","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1096\/fj.201801089R","article-title":"AMH prevents primordial ovarian follicle loss and fertility alteration in cyclophosphamide-treated mice","volume":"33","author":"Sonigo","year":"2019","journal-title":"FASEB J"},{"key":"2022020821442557600_onco13675-bib-0062","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1016\/j.fertnstert.2013.01.135","article-title":"Granulocyte colony-stimulating factor with or without stem cell factor extends time to premature ovarian insufficiency in female mice treated with alkylating chemotherapy","volume":"99","author":"Skaznik-Wikiel","year":"2013","journal-title":"Fertil Steril"},{"key":"2022020821442557600_onco13675-bib-0063","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.2174\/138920112802273245","article-title":"Dexrazoxane for the prevention of cardiac toxicity and treatment of extravasation injury from the anthracycline antibiotics","volume":"13","author":"Doroshow","year":"2012","journal-title":"Curr Pharm Biotechnol"},{"key":"2022020821442557600_onco13675-bib-0064","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1095\/biolreprod.111.097030","article-title":"Dexrazoxane ameliorates doxorubicin-induced injury in mouse ovarian cells","volume":"86","author":"Roti Roti","year":"2012","journal-title":"Biol Reprod"},{"key":"2022020821442557600_onco13675-bib-0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142588","article-title":"Dexrazoxane diminishes doxorubicin-induced acute ovarian damage and preserves ovarian function and fecundity in mice","volume":"10","author":"Kropp","year":"2015","journal-title":"PLoS One"},{"key":"2022020821442557600_onco13675-bib-0066","volume-title":"Available at","author":"The Human Metabolome Database"},{"key":"2022020821442557600_onco13675-bib-0067","author":"The Human Metabolome Database"},{"key":"2022020821442557600_onco13675-bib-0068","doi-asserted-by":"crossref","DOI":"10.1186\/s13048-018-0409-9","article-title":"Beneficial effects of curcumin and capsaicin on cyclophosphamide-induced premature ovarian failure in a rat model","volume":"11","author":"Melekoglu","year":"2018","journal-title":"J Ovarian Res"},{"key":"2022020821442557600_onco13675-bib-0069","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/ptr.2100","article-title":"Shilajit: A review","volume":"21","author":"Agarwal","year":"2007","journal-title":"Phytother Res"},{"key":"2022020821442557600_onco13675-bib-0070","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s00404-015-3924-6","article-title":"Evaluation of preventive effect of shilajit on radiation-induced apoptosis on ovaries","volume":"293","author":"Kececi","year":"2016","journal-title":"Arch Gynecol Obstet"},{"key":"2022020821442557600_onco13675-bib-0071","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1136\/heartjnl-2019-315227","article-title":"Manganese-enhanced MRI of the myocardium","volume":"105","author":"Spath","year":"2019","journal-title":"Heart"},{"key":"2022020821442557600_onco13675-bib-0072","doi-asserted-by":"crossref","DOI":"10.1186\/s12958-018-0426-y","article-title":"Protective effects of mangafodipir against chemotherapy-induced ovarian damage in mice","volume":"16","author":"Qin","year":"2018","journal-title":"Reprod Biol Endocrinol"},{"key":"2022020821442557600_onco13675-bib-0073","author":"The Human Metabolome Database"},{"key":"2022020821442557600_onco13675-bib-0074","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.reprotox.2020.05.005","article-title":"The protective effects of pretreatment with resveratrol in cyclophosphamide-induced rat ovarian granulosa cell injury: in vitro study","volume":"95","author":"Nie","year":"2020","journal-title":"Reprod Toxicol"},{"key":"2022020821442557600_onco13675-bib-0075","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1111\/rda.13274","article-title":"Resveratrol promotes in vitro activation of ovine primordial follicles by reducing DNA damage and enhancing granulosa cell proliferation via phosphatidylinositol 3-kinase pathway","volume":"53","author":"Bezerra","year":"2018","journal-title":"Reprod Domest Anim"},{"key":"2022020821442557600_onco13675-bib-0076","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMoa1315226","article-title":"Idelalisib and rituximab in relapsed chronic lymphocytic leukemia","volume":"370","author":"Furman","year":"2014","journal-title":"N Engl J Med"},{"key":"2022020821442557600_onco13675-bib-0077","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nbt1358","article-title":"A quantitative analysis of kinase inhibitor selectivity","volume":"26","author":"Karaman","year":"2008","journal-title":"Nat Biotechnol"},{"key":"2022020821442557600_onco13675-bib-0078","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S1470-2045(18)30935-5","article-title":"Gene-expression profiling of bortezomib added to standard chemoimmunotherapy for diffuse large B-cell lymphoma (REMoDL-B): An open-label, randomised, phase 3 trial","volume":"20","author":"Davies","year":"2019","journal-title":"Lancet Oncol"},{"key":"2022020821442557600_onco13675-bib-0079","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1007\/s12272-017-0976-0","article-title":"Prediction of drug\u2013drug interaction potential using physiologically based pharmacokinetic modeling","volume":"40","author":"Min","year":"2017","journal-title":"Arch Pharm Res"},{"key":"2022020821442557600_onco13675-bib-0080","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.annonc.2020.09.006","article-title":"Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: ESMO Clinical Practice Guidelines","volume":"31","author":"Lambertini","year":"2020","journal-title":"Ann Oncol"},{"key":"2022020821442557600_onco13675-bib-0081","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1200\/JCO.2018.78.0858","article-title":"Gonadotropin-releasing hormone agonists during chemotherapy for preservation of ovarian function and fertility in premenopausal patients with early breast cancer: A systematic review and meta-analysis of individual patient-level data","volume":"36","author":"Lambertini","year":"2018","journal-title":"J Clin Oncol"},{"key":"2022020821442557600_onco13675-bib-0082","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1200\/JCO.2012.42.8185","article-title":"Gonadotropin-releasing hormone agonist for the prevention of chemotherapy-induced ovarian failure in patients with lymphoma: 1-year follow-up of a prospective randomized trial","volume":"31","author":"Demeestere","year":"2013","journal-title":"J Clin Oncol"},{"key":"2022020821442557600_onco13675-bib-0083","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1200\/JCO.18.00420","article-title":"Utility of gonadotropin-releasing hormone agonists for fertility preservation: Lack of biologic basis and the need to prioritize proven methods","volume":"37","author":"Turan","year":"2019","journal-title":"J Clin Oncol"},{"key":"2022020821442557600_onco13675-bib-0084","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/humrep\/dez047","article-title":"Impact of cancer chemotherapy before ovarian cortex cryopreservation on ovarian tissue transplantation","volume":"34","author":"Poirot","year":"2019","journal-title":"Hum Reprod"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/onco.13675","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/onco.13675","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/26\/6\/492\/42375793\/oncolo_26_6_492.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/26\/6\/492\/42375793\/oncolo_26_6_492.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T21:52:31Z","timestamp":1644357151000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/26\/6\/492\/6520970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,29]]},"references-count":84,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,1,29]]},"published-print":{"date-parts":[[2021,6,1]]}},"URL":"https:\/\/doi.org\/10.1002\/onco.13675","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,6,1]]},"published":{"date-parts":[[2021,1,29]]}}}